Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Photo of Michelle Turner

Michelle Turner

  • Program Analyst
  • Division of Cancer Biology (DCB)
  • Office of the Director

Michelle Turner has expertise in grants policy and administration. She provides management and analyst support for the DCB Office of the Director.

Ms. Turner also acts as the program director for the Multi-Consortia Coordinating (MC^2) Center.

 

Research Programs

Ms. Turner supports activities across DCB Research Programs. 

 

Background

Prior to her work as a program analyst, Ms. Turner was a program associate director for DCB’s Tumor Biology and Microenvironment Branch and Tumor Metastasis Branch. 

She came to DCB because of her interest in facilitating cancer research. 

 

Education 

  • M.S., Biotechnology, John’s Hopkins University 
  • B.S., Biology, University of Mary Washington
     
  • Updated:
Email